(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

REMPLIR - MODELING EPINEURIAL STRUCTURE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

REMPLIR - MODELING EPINEURIAL STRUCTURE

ST13

US500000079414297

Classe

5, 10

Pedido

79414297

Registro

8217291

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

22

Atualização mais recente

21/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10

Data de depósito

16/12/2024

Data de registro

21/04/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

21/04/2026

Última transação

21/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

AU

Examinador

BLAZICH, JOAN MICHELE

Unidade examinadora

N40

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Orthocell Limited

Representantes

Matthew J. Stark PRICE HENEVELD LLP

Classificação técnica

Classes Nice

Classe 5Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Collagen for medical purposes; surgical implants grown from stem cells being living tissue; therapeutic drugs and agents for use in tissue repair and regeneration; pharmaceutical and medical preparations for use in regeneration of damaged bone and soft tissueincluding nerve tissue; surgical and medical dressings; biological preparations for medical purposesfor use in tissue regeneration for tissue repair; biological preparations for medical usefor use in tissue regeneration for tissue repair; dental implant materials being implantable scaffolds comprising biological materials including living cells and collagen; collagen bioinks in the nature of biological tissues intended for subsequent implantation for clinical purposes; biological implants comprised of human or animal connective tissues intended for subsequent implantation; biological implantsliving cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; surgical implants comprised of living tissues; surgical mesh comprised primarily of living tissue; biotechnological preparations for medical purposesliving cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; biodegradable implants for use in guided tissue regenerationliving cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; collagen bioinks in the nature of biological tissue cells intended for subsequent implantation for clinical purposes; engineered human biological tissues being living cells and implantable scaffolds comprising biological materials for use in regenerative medicine; engineered animal biological tissues being living cells and implantable scaffolds comprising biological materials for use in regenerative medicine; biomaterials in the nature of biological tissue cells being living cells for medical purposes; biological tissue being living cells for implantation for use in tissue regeneration for tissue repair; engineered biological tissues being living cells for medical purposes

Classe 10

Orthopaedic apparatusapparatus made from artificial biomaterials for use in the regeneration of bone and soft tissueincluding nerve tissue; orthopaedic articlesapparatus made from artificial biomaterials for use in the regeneration of bone and soft tissueincluding nerve tissue; medical implants made from artificial materials; surgical implants comprised of artificial materials; surgical implants comprised of artificial materials for use in guided tissue regeneration; orthopaedic implantsimplants made from artificial biomaterials for use in the regeneration of bone and soft tissueincluding nerve tissue; artificial orthopaedic implantsimplants made from artificial biomaterials for use in the regeneration of bone and soft tissueincluding nerve tissue; implants being prostheses of artificial biomaterialsbone prostheses and soft tissue prostheses for replacing bone and soft tissue for use in the body; implants being prostheses of artificial biomaterialsdental prostheses for dental surgery; implants being prostheses of artificial biomaterialsbone prostheses for bone surgery; implants being prostheses of artificial biomaterialsdental and bone prostheses for use in facial surgery; implants being prostheses of artificial biomaterialsbone prostheses for use in bone grafting; otological prostheses being prostheses consisting of artificial biomaterials; dental implants; artificial surgical implants comprising artificial biomaterials; therapeutic articles for implantationsurgical implantsmade of artificial materials

Publicações

Histórico de despachos e eventos da marca no USPTO.

22 publicações encontradas

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

21/07/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

25/06/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/06/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

08/06/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

21/04/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

21/04/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/03/2026

PUBO

PUBLISHED FOR OPPOSITION

03/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/02/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/02/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

29/01/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/01/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

29/01/2026

RFNT

REFUSAL PROCESSED BY IB

15/08/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

30/07/2025

RFRR

REFUSAL PROCESSED BY MPU

30/07/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/06/2025

CNRT

NON-FINAL ACTION WRITTEN

09/06/2025

DOCK

ASSIGNED TO EXAMINER

02/06/2025

MAFR

APPLICATION FILING RECEIPT MAILED

10/01/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/01/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/01/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace REMPLIR - MODELING EPINEURIAL STRUCTURE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.